[ad_1]
“The president has mentioned many times that he is ready to be vaccinated, as soon as there is an opportunity to do so. The president is also ready to be vaccinated with any vaccine that is used in Lithuania, including the AstraZeneca vaccine, ”the adviser said at a press conference on Tuesday.
Questions about the vaccine from the British and Swedish company AstraZeneca arose after the European Medicines Agency approved the vaccine in late January, noting that there were not yet enough studies on whether the vaccine provides effective protection to people over the age of 55. years.
The president is also ready to be vaccinated with whatever vaccine is used in Lithuania.
The discussions have also spawned posts about the vaccine’s side effects on social media shared by some vaccinated people.
The Ministry of Health announced last week that AstraZeneca will be available to all adults, regardless of age.
Director of the Center for Hematology, Oncology and Transfusion of Clínicas Santara prof. Laimonas Griškevičius previously told BNS that it is important to separate information on the immune response and clinical trials on the effectiveness of the vaccine.
“The immune response is determined by blood tests, which specifically analyze the production of antibodies against the so-called needle protein in individuals. A first phase study was conducted in which different age groups were compared. Antibody production did not differ between age groups, ”commented L. Griškevičius.
The immune response is determined by blood tests, which specifically analyze the production of antibodies against the so-called needle protein in individuals.
“If we say that a person who is 70 years old has the same amount of antibodies as a person who is 20 years old, and if the antibodies are an indirect indication that a person has immunity and both a person in their twenties and in their seventies have the same immunity, we say that these antibodies protect, we suppose. But to prove it, we have to compare clinically, between those who received the vaccine in that age group and those who did not, “he said.
According to the professor, it was this comparison that was the most valid and lacked more older people to “respond reliably if the vaccine is clinically effective in that age group.”
The State Drug Control Agency (IARC) reported Monday that 802 reports of adverse reactions to COVID-19 vaccines have been received since the start of vaccination.
The vaccine received 585 notifications for BioNTech and Pfizer, 34 notifications for Moderna, and 172 notifications for AstraZeneca.
[ad_2]
